abstract |
The present invention relates to a novel crystalline form of 2,3-dimethyl-8- (2,6-dimethylbenzylamino) -N-hydroxyethyl-imidazo [1,2-a] pyridine-6-carboxamide mesylate salt and Relates to the mixture. Furthermore, the invention also relates to methods for obtaining them, the use of the compounds for the treatment of gastrointestinal diseases, and pharmaceutical compositions comprising them. |